THE CONTENT OF ANTIGENS 1,2 AND 3 IN STRAINS OF BORDETELLA PERTUSSIS AND IN VACCINES
- PMID: 14285295
- PMCID: PMC1928309
THE CONTENT OF ANTIGENS 1,2 AND 3 IN STRAINS OF BORDETELLA PERTUSSIS AND IN VACCINES
Abstract
A comparison was made of the content of heat-labile antigens 1, 2 and 3 in strains of Bordetella pertussis isolated in Toronto, and the content of the same antigens in vaccines being used in that community. Antisera were prepared in rabbits and made monospecific by absorptions. Antigens were detected by slide agglutination tests. Of the 58 strains examined, 56 contained antigens 1 and 3 but no antigen 2 was detected. Nine of these strains were isolated from children who had received a full course of vaccination and had subsequently developed pertussis. All 10 vaccines examined contained antigen 1; two, possibly four, contained no antigen 2; and seven of the 10 vaccines were weak or deficient in antigen 3. This work suggests that improved protection might be attained by the use of vaccines containing adequate amounts of all three antigens.
Similar articles
-
Bordetella pertussis serotypes in Canada.Can Med Assoc J. 1978 Oct 7;119(7):722-4. Can Med Assoc J. 1978. PMID: 213182 Free PMC article.
-
Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.BMC Immunol. 2015 Jul 1;16:40. doi: 10.1186/s12865-015-0090-3. BMC Immunol. 2015. PMID: 26129684 Free PMC article.
-
Efficacy of whooping-cough vaccines used in the United Kingdom before 1968. A preliminary report to the Director of the Public Health Laboratory service by the Public Health Laboratory Service Whooping-Cough Committee and Working Party.Br Med J. 1969 Nov 8;4(5679):329-33. Br Med J. 1969. PMID: 4318320 Free PMC article.
-
Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.Pathog Dis. 2015 Oct;73(7):ftv055. doi: 10.1093/femspd/ftv055. Epub 2015 Aug 4. Pathog Dis. 2015. PMID: 26242280 Review.
-
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23. Expert Rev Vaccines. 2014. PMID: 24953157 Review.
Cited by
-
The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period.J Hyg (Lond). 1976 Apr;76(2):265-75. doi: 10.1017/s0022172400055169. J Hyg (Lond). 1976. PMID: 177703 Free PMC article.
-
Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s.J Bacteriol. 1966 Jun;91(6):2175-9. doi: 10.1128/jb.91.6.2175-2179.1966. J Bacteriol. 1966. PMID: 4287581 Free PMC article.
-
Antigens of Bordetella pertussis V. Separation of Agglutinogen 1 and Mouse-Protective Antigen.Infect Immun. 1971 Feb;3(2):243-8. doi: 10.1128/iai.3.2.243-248.1971. Infect Immun. 1971. PMID: 16557960 Free PMC article.
-
IMMUNIZATION AGAINST WHOOPING COUGH.Br Med J. 1965 Jul 3;2(5452):2-3. Br Med J. 1965. PMID: 14305349 Free PMC article. No abstract available.
-
Bordetella pertussis culture having only species factor 1.J Bacteriol. 1966 May;91(5):1759-62. doi: 10.1128/jb.91.5.1759-1762.1966. J Bacteriol. 1966. PMID: 4287072 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources